Latest News:
18.09.2009
Proteins in XL: TU München reports about XL-protein.
17.09.2009
XL-protein GmbH and Bayerische Patent Allianz GmbH have signed an exclusive licensing agreement.
News
September, 18- Many biopharmaceuticals comprise small proteins that are quickly eliminated from the body. Scientists at the Technische Universitaet Muenchen (TUM) combine such small proteins with a kind of molecular balloon that swells and thus prolongs the half-life of these proteins in the body. The TUM spin-off XL-protein GmbH has now started to further develop this new technology with blockbuster potential.
